Vanta Bioscience Limited
VANTABIO
Rank in Stocks
#32441
Vanta Bioscience Limited functions as an all-encompassing preclinical contract... Vanta Bioscience Limited functions as an all-encompassing preclinical contract research organization (CRO). The firm extends a wide array of specialized offerings, including Discovery Toxicology, comprehensive assessments for Agro-Chemicals and overall Chemical Safety, Biocompatibility Studies, Diet Formulation, and Batch Release Testing. This company commenced operations on April 29, 2016, and its main office is situated in Hyderabad, India.
Share Price
$0.2114946
Last synced: 2026-11-13
Market Cap
$1.50M
Change (1 day)
-0.17%
Change (1 year)
-20.20%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Vanta Bioscience Limited (VANTABIO)
Category
Healthcare
EPS for Vanta Bioscience Limited (VANTABIO)
EPS as of March 2026 TTM: $0.02
According to Vanta Bioscience Limited's latest financial reports, its current EPS (TTM) is $0.02. At the end of 2025 the company had an EPS of $-0.09, a decrease compared to its 2024 EPS of $-0.04.
EPS history for Vanta Bioscience Limited from 2018 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $0.02 | -117.22% |
| 2025 | $-0.09 | 100.91% |
| 2024 | $-0.04 | -64.80% |
| 2023 | $-0.13 | -7,044.44% |
| 2022 | 0.00 | -81.44% |
| 2021 | $0.01 | -54.03% |
| 2020 | $0.02 | 33.54% |
| 2019 | $0.02 | 2,157.14% |
| 2018 | 0.00 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $15.66 | 100,932.26% |
US
|
|
| $-7.07 | -45,712.90% |
US
|
|
| $-5.29 | -34,229.03% |
AU
|
|
| $12.73 | 82,043.23% |
BE
|
|
| $21.56 | 138,996.77% |
NL
|
Questions about Vanta Bioscience Limited's earnings per share (EPS)
What is Vanta Bioscience Limited's earnings per share (EPS)?
Vanta Bioscience Limited's earnings per share (EPS) over the last twelve months is $0.02, as of Mar 2026.
What was Vanta Bioscience Limited's earnings per share (EPS) in 2025?
In 2025, Vanta Bioscience Limited's earnings per share (EPS) was $-0.09, compared with $-0.04 in 2024.
How has Vanta Bioscience Limited's earnings per share (EPS) changed since 2020?
From 2020 to 2025, Vanta Bioscience Limited's earnings per share (EPS) was highest in 2020 ($0.02) and lowest in 2023 ($-0.13).
How does Vanta Bioscience Limited's earnings per share (EPS) compare with similar companies?
Vanta Bioscience Limited's earnings per share (EPS) ($0.02) is higher than that of 2 of the 5 similar companies listed above. The highest among them is Argenx SE, with $21.56.